FDA inspection of Dr Reddy's Mexican facility could start to clear import block
This article was originally published in Scrip
Executive Summary
Dr Reddy's Mexican facility, which has been under the scanner for current good manufacturing practice deviations, is expected to be inspected by the US FDA sometime next week. The move is seen as part of significant steps towards resolving GMP concerns surrounding the unit after the FDA issued an import alert for certain products manufactured there in June last year.